IRIS Accounts Production v23.3.0.418 05804366 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false true false Ordinary Ordinary iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh058043662022-03-31058043662023-03-31058043662022-04-012023-03-31058043662021-03-31058043662021-04-012022-03-31058043662022-03-3105804366ns10:Originalns15:EnglandWales2022-04-012023-03-3105804366ns14:PoundSterlingns10:Original2022-04-012023-03-3105804366ns10:Originalns10:Director12022-04-012023-03-3105804366ns10:Original2022-04-012023-03-3105804366ns10:Original2023-03-3105804366ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3105804366ns10:Originalns10:SmallEntities2022-04-012023-03-3105804366ns10:Originalns10:AuditExemptWithAccountantsReport2022-04-012023-03-3105804366ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3105804366ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3105804366ns10:Originalns10:FullAccounts2022-04-012023-03-3105804366ns10:Originalns10:OrdinaryShareClass12022-04-012023-03-3105804366ns10:Originalns10:OrdinaryShareClass22022-04-012023-03-3105804366ns10:OrdinaryShareClass3ns10:Original2022-04-012023-03-3105804366ns10:Originalns10:Director22022-04-012023-03-3105804366ns10:Originalns10:Director32022-04-012023-03-3105804366ns10:Originalns10:Director42022-04-012023-03-3105804366ns10:CompanySecretary1ns10:Original2022-04-012023-03-3105804366ns10:Originalns10:RegisteredOffice2022-04-012023-03-3105804366ns10:Original2021-04-012022-03-3105804366ns10:Original2022-03-3105804366ns10:Originalns5:CurrentFinancialInstruments2023-03-3105804366ns10:Originalns5:CurrentFinancialInstruments2022-03-3105804366ns5:ShareCapitalns10:Original2023-03-3105804366ns5:ShareCapitalns10:Original2022-03-3105804366ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3105804366ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3105804366ns10:Originalns5:PlantMachinery2022-04-012023-03-3105804366ns10:Originalns10:OrdinaryShareClass12021-04-012022-03-3105804366ns10:Originalns5:PlantMachinery2022-03-3105804366ns10:Originalns5:PlantMachinery2023-03-3105804366ns10:Originalns5:PlantMachinery2022-03-3105804366ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3105804366ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3105804366ns5:KeyManagementPersonnel2022-04-012023-03-3105804366ns5:KeyManagementPersonnel2023-03-3105804366ns5:DividendsPaidTransactionsns5:KeyManagementPersonnel2022-04-012023-03-31
REGISTERED NUMBER: 05804366 (England and Wales)














Report of the Directors and

Unaudited Financial Statements

for the Year Ended 31 March 2023

for

XLNT (HEALTH) LIMITED

XLNT (HEALTH) LIMITED (REGISTERED NUMBER: 05804366)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Report of the Directors 2

Chartered Accountants' Report 3

Income Statement 4

Balance Sheet 5

Notes to the Financial Statements 6


XLNT (HEALTH) LIMITED

Company Information
for the Year Ended 31 March 2023







DIRECTORS: M A P Cattini
P Labadini
L D Cattini
M Labadini





SECRETARY: M A P Cattini





REGISTERED OFFICE: 107 Hindes Road
Harrow
Middlesex
HA1 1RU





BUSINESS ADDRESS: Whittington Hospital
1st Floor
Magdala Avenue
London
N19 5NF





REGISTERED NUMBER: 05804366 (England and Wales)





ACCOUNTANTS: Hill Wooldridge & Co.
107 Hindes Road
Harrow
Middlesex
HA1 1RU

XLNT (HEALTH) LIMITED (REGISTERED NUMBER: 05804366)

Report of the Directors
for the Year Ended 31 March 2023

The directors present their report with the financial statements of the company for the year ended 31 March 2023.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of catering services.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 April 2022 to the date of this report.

M A P Cattini
P Labadini

Other changes in directors holding office are as follows:

L D Cattini - appointed 4 May 2022
M Labadini - appointed 4 May 2022

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





P Labadini - Director


8 November 2023

Chartered Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
XLNT (Health) Limited


In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of XLNT (Health) Limited for the year ended 31 March 2023 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of XLNT (Health) Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of XLNT (Health) Limited and state those matters that we have agreed to state to the Board of Directors of XLNT (Health) Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than XLNT (Health) Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that XLNT (Health) Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of XLNT (Health) Limited. You consider that XLNT (Health) Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of XLNT (Health) Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Hill Wooldridge & Co.
107 Hindes Road
Harrow
Middlesex
HA1 1RU


8 November 2023

XLNT (HEALTH) LIMITED (REGISTERED NUMBER: 05804366)

Income Statement
for the Year Ended 31 March 2023

2023 2022
Notes £    £   

TURNOVER 398,165 322,052

Cost of sales 128,884 93,963
GROSS PROFIT 269,281 228,089

Administrative expenses 207,705 176,522
61,576 51,567

Other operating income 143,757 -
OPERATING PROFIT 205,333 51,567

Interest receivable and similar income 351 19
205,684 51,586

Interest payable and similar expenses 2 43
PROFIT BEFORE TAXATION 205,682 51,543

Tax on profit 39,080 9,793
PROFIT FOR THE FINANCIAL YEAR 166,602 41,750

XLNT (HEALTH) LIMITED (REGISTERED NUMBER: 05804366)

Balance Sheet
31 March 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 2,511 3,356

CURRENT ASSETS
Stocks 3,500 1,000
Debtors 6 3,963 20,646
Cash at bank and in hand 265,743 245,734
273,206 267,380
CREDITORS
Amounts falling due within one year 7 65,299 187,850
NET CURRENT ASSETS 207,907 79,530
TOTAL ASSETS LESS CURRENT
LIABILITIES

210,418

82,886

PROVISIONS FOR LIABILITIES 65 135
NET ASSETS 210,353 82,751

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 210,253 82,651
SHAREHOLDERS' FUNDS 210,353 82,751

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 8 November 2023 and were signed on its behalf by:





P Labadini - Director


XLNT (HEALTH) LIMITED (REGISTERED NUMBER: 05804366)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

XLNT (Health) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2022 - 5 ) .

4. DIVIDENDS
2023 2022
£    £   
Ordinary shares of £1 each
Interim 39,000 37,000

XLNT (HEALTH) LIMITED (REGISTERED NUMBER: 05804366)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2022
and 31 March 2023 97,961
DEPRECIATION
At 1 April 2022 94,605
Charge for year 845
At 31 March 2023 95,450
NET BOOK VALUE
At 31 March 2023 2,511
At 31 March 2022 3,356

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 3,963 20,646

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 52,465 15,053
Other creditors 12,834 172,797
65,299 187,850

8. RELATED PARTY DISCLOSURES

During the year, the company operated a loan account with the directors. At the balance sheet date the company
owed the directors £6,400 (2022: £6,400).

During the year, the company issued dividends of £39,000 to the directors (2022: £37,000).